prt12396
·Code: PRT12396
prt12396: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| Prelude Therapeutics Inc (PRLD) | Phase 1 |
Clinical Trials (1)
A Phase 1, Open-Label, Multi-Center, Safety and Efficacy Study of PRT12396 in Participants With Polycythemia Vera and Myelofibrosis
Frequently asked questions
Who is developing prt12396?
prt12396 is being developed by Prelude Therapeutics Inc.
How many clinical trials involve prt12396?
BioSniper tracks 1 clinical trial involving prt12396.
Get deeper analysis on prt12396
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis